High performance biodegradable polymer

trellicell is a resorbable polymer based scaffold that can be used to culture any cell type in large formats

trellicell easily fits for various applications and uses across a wide range of industries such as medical, pharmaceutical, food, artificial tissue regeneration etc for cell culture and tissue engineering.


We have identified extensive applications for our cell growth scaffolds for the development of unprecedented new applications in many areas. To begin with we are focussing on the following three primary applications areas for trellicell scaffolds.

Our Team

trellicell is being developed by Molekulare Biotechnolgie e.U., Austria based biotechnology company working towards revolutionizing the use of biodegradable polymers for wide variety of cell growth applications. trellicell offers high-performance biodegradable polymers suited to develop many innovative and life changing products for a broad range of industries.

Developed by a team of world class researchers and backed by medtech innovators and investors with extensive industry experience in bringing new products to life, trellicell is set to disrupt the artificial cell growth Industry in coming years.

Prof. Dr. Helmut Schwab

CEO & Founder

Dr. Stefan Zopf

Business Strategy & Investor

Kumari Anshu

Strategy & Growth Manager

Florian Meyer

Project Management & IT


Solve real life world problems related to health and food by innovating superior polymers.


To become industry leader in developing biodegradable scaffolds promoting artificial cell growth.

Molekulare Biotechnologie e.U.
Mariagrünerstraße 91
8043 Graz
Please contact us via
Molekulare Biotechnologie e.U.
Mariagrünerstraße 91
8043 Graz


trellicell technology is utilizing a scaffold composed of specific polymer compounds that deliver the physical properties from polymer, while still being 100% absorbable.

trellicell’s dissolvable properties can be altered to better fit the specific needs. One part is that the speed of the dissolving process can be adjusted upon need.
This acts to provide tissue-level structural support to cells, thus encouraging cell adhesion and proliferation. These are the key factors that enable tissue regeneration. trellicell is utilizing this technology to develop products for the organ growth and regeneration, wound repair, resorbable implants and cultured food.

trellicell also helps in controlled release of substances such as drugs or antibiotics that help in wound repair and healing.

Market overview

Resorbable polymer scaffolds


trellicell Net is implants, stents or surface coverage made of a resorbable polymer. It is intended for use in fracture repair and reconstructive procedures, controlled release of drugs as well as for wound healing and repair.

Bone Implants

In the early stages of bone healing trellicell Net preserves fixation. Over time, the implant gradually decomposes, and the stresses are steadily transferred to the healing tissue, Providing continuous support for new tissue growth.

Properties of trellicell-Net for bone implants

Drug Delivery

trellicell drug delivery capsules help in controlled release of drugs in the body. These capsules are  programmed to release drugs at a precise, predictable time, so that multiple doses of a drug or vaccine can be delivered over an extended time period with just one injection or oral capsule.

Properties of trellicell-Net for drug delivery

Resorbable implant market overview

Market growth drivers


trellicell resorbable polymer based scaffolds supports growth of cultured meat.

To culture three-dimensional meat, the cells are grown on  scaffolds that direct its structure and order. With the help of trellicell resorbable scaffold muscle tissue is developed from the growth medium and organized in a three-dimensional structure for the end product.

Advantage of Cultured meat are

Artificial meat market overview

Market growth drivers


trellicell scaffold with its unique properties prove to be ideal for regenerative growth of tissues and organs. trellicell 3D scaffold structures are designed to provide support to stem cells for organoid growth.

Organoids help in screening the efficacy of drugs against various human diseases. The unique capacity of trellicell Organoids to recapitulate characteristics of the personalized organ they originate from opens up new possibilities for research, drug discovery and development. Testing drugs on 3D bioprinted organs has the potential to optimize and accelerate the drug development process.

Some of the greatest impacts of organoid development are following:

Properties of trellicell scaffold for organ growth

Industry Overview

Industry growth drivers

Helmut Schwab

CEO & Founder
Univ.Prof.i.R. Dipl.Ing. Dr.Techn.

Institute of Molecular Biotechnology,

Graz University of  Technology &

Austrian Centre of Industrial Biotechnology GmbH (ACIB)

University education:

1968 – 1973: Diploma study (degree “Dipl.Ing.”) on Technical Chemistry with specialization on Biochemistry/Biotechnology.

1976 – 1980: Doctoral thesis “Transfer of Plasmid-DNA into the bacterium Alcaligenes eutrophus H16″

Professional career:

1974 – 1985: Assistant at the Institute of Biotechnology of TU Graz (Graz University of 1979:

1979: 6 months period in industry (Vogelbusch GmbH, Vienna), Yeast fermentation at 200 m³ scale (continuous)

1983 – 1985: two years period in industry, establishing molecular genetics group, Sandoz (now Novartis) GmbH , Kundl

1985 – 2003: assistant/associate  professor at the Institute of Biotechnology, University of Technology, Graz.

1988: Habilitation: “Biotechnology with Special Emphasis on Gene Technology”

1995: Fulbright Senior Research Fellow, Sabbatical at the Center for Molecular Genetics, UCSD, La Jolla, CA

Since 2002: Foundation and leading (CEO) of SME “Molekulare Biotechnologie GmbH”

2003 – Sept 2015: Full Professor (chair) of Molecular Biotechnology at Graz University of Technology

Since Oct. 2015: officially retired, still active in research and teaching, part time employment at TU Graz

Since March 2017: Part time employment at Austrian Centre for Industrial Biotechnology – Key Researcher, PI for projects on Cell and protein engineering

Recent major research activities:

Research interests are focussed on molecular biotechnology and include heterologous gene expression (protein and metabolite production) in industrial microorganisms (bacteria, fungi) , molecular enzymology,  enzyme engineering and microbial cell engineering for cell factory construction, biological carbon dioxide fixation for bio-production of chemicals, fuels and biopolymers.  Projects funded by national (FWF, FFG, CDG) and international (EU) agencies as well as industry.

Various industry co-operation projects, mostly in the frame of the Austrian Center for Industrial Biotechnology (ACIB) and of the Christian Doppler Laboratories: Topics include recruiting and developing industrial enzymes, heterologous expression of proteins in bacteria and fungi, enzyme engineering by rational and random approaches.

2002-2009: Key Researcher at the Competence Centre “Applied Biocatalysis”

2010-2014: Head of Area “Protein Design and Engineering” and Key researcher of the 

Austrian Centre of Industrial Biotechnology (ACIB).

2015: Head of the Area “Bioprospecting and Synthetic Biology” of the Austrian Centre of Industrial Biotechnology (ACIB).

2015: retired from position as university professor, still active in different research projects, mainly in the frame of ACIB (industry cooperation)

Major activities in national und international bodies:

2002:-2008: Vice president & President of the Austrian Society for Biotechnology

Member of External Scientific Advisory Boards 

  • – Cell Factory Program of Framework V (EU)
  • – Competence Centre “White Biotechnology – Green Chemistry”, Finland
  • – “GENOMIK Transfer” program, Germany
  • – “Bielefeld Genome Network”

Editorial activities:

Editor of “Journal of Biotechnology”

Board of editors of  “Applied Microbiology and Biotechnology”

Editor of FEMS Microbiology Reviews (2011-2013)


2000: DSM Research award

2006: Dr. Wolfgang Houska Award , 1st Price (Team member)

2007: DSM Innovation Award

2009: Dr. Wolfgang Houska Award, recognition price (Team member)

Publications & Patents: 

> 30 patent applications

> 140 publications in scientific journals

Stefan Zopf

Business Strategy & Investor

With an academic background in Economics and Engineering I started my career in Business Development with international large corporations.

My time in the Bay Area triggered my passion for innovation and now I am a full time entrepreneur and investor, always looking to push another exciting new business opportunity.

Kumari Anshu

Business Strategy & Growth Manager

Anshu graduated top of her class from California State University, East Bay, USA with an MBA degree specializing in Finance. 

She specializes in consulting and providing strategic support to start-ups, growth companies and investors to ideate, evaluate, capitalize and scale new products and services.

Florian Meyer

Project Management & IT

Still studying at the Technical University of Vienna, Florian was already working part-time as web developer implementing proprietary CM-Systems.

For his master thesis he had the opportunity to implement the mobile app for one of the 4 largest banks in Austria. Taking it, he switched to Android development. By today he has built an impressive track record reaching millions of people with apps from the fields of finance, arts, government, sports and IT.